Department of Critical Care Medicine, McGill University, Montreal, QC, Canada.
Division of Anaesthetics, Pain Medicine, and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Crit Care Med. 2024 Nov 1;52(11):1768-1780. doi: 10.1097/CCM.0000000000006390. Epub 2024 Aug 12.
Machine learning (ML) tools for acute respiratory distress syndrome (ARDS) detection and prediction are increasingly used. Therefore, understanding risks and benefits of such algorithms is relevant at the bedside. ARDS is a complex and severe lung condition that can be challenging to define precisely due to its multifactorial nature. It often arises as a response to various underlying medical conditions, such as pneumonia, sepsis, or trauma, leading to widespread inflammation in the lungs. ML has shown promising potential in supporting the recognition of ARDS in ICU patients. By analyzing a variety of clinical data, including vital signs, laboratory results, and imaging findings, ML models can identify patterns and risk factors associated with the development of ARDS. This detection and prediction could be crucial for timely interventions, diagnosis and treatment. In summary, leveraging ML for the early prediction and detection of ARDS in ICU patients holds great potential to enhance patient care, improve outcomes, and contribute to the evolving landscape of precision medicine in critical care settings. This article is a concise definitive review on artificial intelligence and ML tools for the prediction and detection of ARDS in critically ill patients.
机器学习(ML)工具在急性呼吸窘迫综合征(ARDS)的检测和预测中被越来越多地使用。因此,了解这些算法的风险和益处与床边的相关性是相关的。ARDS 是一种复杂而严重的肺部疾病,由于其多因素性质,精确定义可能具有挑战性。它通常是对各种潜在医疗状况的反应,如肺炎、败血症或创伤,导致肺部广泛炎症。ML 在支持 ICU 患者中 ARDS 的识别方面显示出了有前途的潜力。通过分析各种临床数据,包括生命体征、实验室结果和影像学发现,ML 模型可以识别与 ARDS 发展相关的模式和风险因素。这种检测和预测对于及时干预、诊断和治疗至关重要。总之,利用 ML 对 ICU 患者的 ARDS 进行早期预测和检测具有很大的潜力,可以增强患者护理、改善结果,并为重症监护环境中精准医学的发展做出贡献。本文是一篇关于人工智能和 ML 工具在危重病患者中预测和检测 ARDS 的简明权威综述。
Crit Care Med. 2024-11-1
J Med Internet Res. 2025-5-20
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024-4
J Transl Med. 2025-1-13
Cochrane Database Syst Rev. 2020-12-21
medRxiv. 2025-8-12
Front Artif Intell. 2025-5-27
Med Sci Monit. 2025-6-5
Int J Environ Res Public Health. 2025-1-12